“Cytori Therapeutics, Inc. (Cytori Therapeutics) is a US-based pharmaceutical company. It undertakes the development of cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease as well as for the repair soft tissue defects. Cytori has three key product lines, namely, the Celution family, which includes the first and only broadly available device that provides clinical grade adipose derived autologous stem and regenerative cells for re-injection into the patient at the point of care; and the StemSource family for use in laboratory research and stem cell banking. The company offers its products to the physicians and patients at the point-of-care by its proprietary technologies and products, including the Celution System product family. Cytori Therapeutics is headquartered in San Diego, California, the US.
Cytori Therapeutics, Inc. (CYTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including...